Mycophenolate mofetil in primary central nervous system vasculitis

Abstract Objective To evaluate the efficacy and safety of mycophenolate mofetil (MMF) in adult primary central nervous system vasculitis (PCNSV). Methods We studied a cohort of 163 patients with PCNSV who were seen at the Mayo Clinic from 1983 to 2011. We compared patients treated with MMF and those...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in arthritis and rheumatism 2015-08, Vol.45 (1), p.55-59
Hauptverfasser:	Salvarani, Carlo, MD, Brown, Robert D., MD, MPH, Christianson, Teresa J.H, Huston, John, MD, Giannini, Caterina, MD, Miller, Dylan V., MD, Muratore, Francesco, MD, Hunder, Gene G., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Cyclophosphamide - therapeutic use Drug Therapy, Combination Female Humans Immunosuppressive Agents - therapeutic use Male Middle Aged Mycophenolate mofetil Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use PCNSV Remission Induction Rheumatology Therapy Treatment Outcome Vasculitis Vasculitis, Central Nervous System - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!